These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19481452)

  • 1. Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.
    Velmourougane G; Raju R; Bricard G; Im JS; Besra GS; Porcelli SA; Howell AR
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3386-8. PubMed ID: 19481452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
    Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
    Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
    Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
    Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
    ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
    Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
    J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminocyclitol-substituted phytoceramides and their effects on iNKT cell stimulation.
    Harrak Y; Barra CM; Bedia C; Delgado A; Castaño AR; Llebaria A
    ChemMedChem; 2009 Oct; 4(10):1608-13. PubMed ID: 19739197
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile.
    Toba T; Murata K; Futamura J; Nakanishi K; Takahashi B; Takemoto N; Tomino M; Nakatsuka T; Imajo S; Goto M; Yamamura T; Miyake S; Annoura H
    Bioorg Med Chem; 2012 May; 20(9):2850-9. PubMed ID: 22480852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
    Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
    Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
    Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
    Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
    Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
    Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.
    Devera TS; Joshi SK; Aye LM; Lang GA; Ballard JD; Lang ML
    PLoS One; 2011; 6(8):e23817. PubMed ID: 21858226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
    Melo AM; Zhang L; Dockry ÉF; Petrasca A; Ghnewa YG; Breen EP; Morrissey ME; O'Reilly C; Bruen R; O'Meara A; Lysaght J; Zhu X; Doherty DG
    Glycobiology; 2018 Jul; 28(7):512-521. PubMed ID: 29688330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
    Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
    J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
    Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
    Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
    Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
    Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct APCs explain the cytokine bias of α-galactosylceramide variants in vivo.
    Bai L; Constantinides MG; Thomas SY; Reboulet R; Meng F; Koentgen F; Teyton L; Savage PB; Bendelac A
    J Immunol; 2012 Apr; 188(7):3053-61. PubMed ID: 22393151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.
    Tohn R; Blumenfeld H; Haeryfar SM; Veerapen N; Besra GS; Porcelli SA; Delovitch TL
    Clin Exp Immunol; 2011 Apr; 164(1):26-41. PubMed ID: 21361909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.